Clot reduction prior to embolectomy: mSAVE as a first-line technique for large clots.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 18 03 2019
accepted: 16 04 2019
entrez: 10 5 2019
pubmed: 10 5 2019
medline: 15 1 2020
Statut: epublish

Résumé

The "Stent retriever Assisted Vacuum-locked Extraction" (SAVE) technique is a promising embolectomy method for intracranial large vessel occlusion (LVO). We report our experience using a modified SAVE (mSAVE) approach for clot reduction prior to embolectomy in acute ischemic stroke patients with large clots. We retrospectively analyzed 20 consecutive patients undergoing mSAVE in our center due to intracranial LVO. Angiographic data (including first-pass and overall complete reperfusion, defined as an expanded Thrombolysis in Cerebral Infarction (eTICI) score of 3, rate of successful reperfusion (eTICI ≥2c), number of passes, time from groin puncture to reperfusion) and clinical data (favorable outcome at 90 days, defined as modified Rankin Scale (mRS) ≤2) were assessed. First-pass and overall eTICI 3 reperfusion was reached in 13/20 (65%) and 14/20 (70%), respectively. The rate of successful reperfusion (eTICI ≥2c) after one pass was 85% and on final angiogram 90% with an average number of 1.1 ± 0.3 attempts. Eight out of 11 (73%) ICA occlusions were reperfused successfully and 5 (46%) completely after a single pass. Median groin to reperfusion time was 33 minutes (IQR 25-46). A favorable clinical outcome was achieved in 9/20 (45%) patients at discharge and after 90 days, respectively. Clot reduction followed by embolectomy (mSAVE) is feasible and may be an important tool in the treatment of large clots.

Identifiants

pubmed: 31071109
doi: 10.1371/journal.pone.0216258
pii: PONE-D-19-07320
pmc: PMC6508681
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0216258

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Radiology. 2015 May;275(2):510-20
pubmed: 25633505
Sci Rep. 2017 Nov 21;7(1):15938
pubmed: 29162921
Stroke. 2018 Jul;49(7):1669-1677
pubmed: 29880554
AJNR Am J Neuroradiol. 2009 Mar;30(3):525-31
pubmed: 19147716
JAMA. 2017 Aug 1;318(5):443-452
pubmed: 28763550
Stroke. 2017 Nov;48(11):3152-3155
pubmed: 29018132
Stroke. 2007 Mar;38(3):967-73
pubmed: 17272772
Stroke. 2013 Dec;44(12):3553-6
pubmed: 24105699
J Neurointerv Surg. 2017 Mar;9(3):253-256
pubmed: 26975839
Neuroradiology. 2012 Nov;54(11):1261-5
pubmed: 22552837
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
J Neurointerv Surg. 2017 Apr;9(4):366-369
pubmed: 27073195
AJNR Am J Neuroradiol. 2017 Jul;38(7):1368-1371
pubmed: 28473346
J Neurointerv Surg. 2019 Feb;11(2):114-118
pubmed: 29858396
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
Stroke. 2016 Dec;47(12):2972-2978
pubmed: 27827328
Stroke. 2018 Mar;49(3):660-666
pubmed: 29459390
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Stroke. 2018 Dec;49(12):2969-2974
pubmed: 30571428
J Neurointerv Surg. 2016 Jun;8(6):e24
pubmed: 26019186
Clin Neuroradiol. 2019 Dec;29(4):669-676
pubmed: 30027326

Auteurs

Marios-Nikos Psychogios (MN)

Department of Neuroradiology, University Medical Center Goettingen, Goettingen, Germany.
Department of Neurology, University Medical Center Goettingen, Goettingen, Germany.

Ioannis Tsogkas (I)

Department of Neuroradiology, University Medical Center Goettingen, Goettingen, Germany.

Alex Brehm (A)

Department of Neuroradiology, University Medical Center Goettingen, Goettingen, Germany.

Amelie Hesse (A)

Department of Neuroradiology, University Medical Center Goettingen, Goettingen, Germany.

Ryan McTaggart (R)

Department of Radiology, Neurology, and Neurosurgery, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.

Mayank Goyal (M)

Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.

Ilko Maier (I)

Department of Neuroradiology, Clinic for Radiology & Nuclear Medicine, University Hospital Basel, Basel, Switzerland.

Marlena Schnieder (M)

Department of Neuroradiology, Clinic for Radiology & Nuclear Medicine, University Hospital Basel, Basel, Switzerland.

Daniel Behme (D)

Department of Neuroradiology, University Medical Center Goettingen, Goettingen, Germany.

Volker Maus (V)

Department of Neuroradiology, University Medical Center Goettingen, Goettingen, Germany.
Department of Radiology, Neuroradiology and Nuclear Medicine, Ruhr University Bochum, Knappschaftskrankenhaus Bochum, Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH